The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global RNAi Medicine Market Research Report 2024
Synopsis
The global RNAi Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for RNAi Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Medicine.
Report Scope
The RNAi Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNAi Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Suzhou Ribo Life Science Co.,Ltd.
Sirnaomics
GemmaPharma
RiboBio
Segment by Type
siRNA
miRNA
piRNA
Others
Segment by Application
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global RNAi Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for RNAi Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Medicine.
Report Scope
The RNAi Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNAi Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Suzhou Ribo Life Science Co.,Ltd.
Sirnaomics
GemmaPharma
RiboBio
Segment by Type
siRNA
miRNA
piRNA
Others
Segment by Application
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 siRNA
1.2.3 miRNA
1.2.4 piRNA
1.2.5 Others
1.3 Market by Application
1.3.1 Global RNAi Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery & Development
1.3.3 Therapeutics
1.3.4 Drug Delivery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Medicine Market Perspective (2019-2030)
2.2 RNAi Medicine Growth Trends by Region
2.2.1 Global RNAi Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNAi Medicine Historic Market Size by Region (2019-2024)
2.2.3 RNAi Medicine Forecasted Market Size by Region (2025-2030)
2.3 RNAi Medicine Market Dynamics
2.3.1 RNAi Medicine Industry Trends
2.3.2 RNAi Medicine Market Drivers
2.3.3 RNAi Medicine Market Challenges
2.3.4 RNAi Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Medicine Players by Revenue
3.1.1 Global Top RNAi Medicine Players by Revenue (2019-2024)
3.1.2 Global RNAi Medicine Revenue Market Share by Players (2019-2024)
3.2 Global RNAi Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNAi Medicine Revenue
3.4 Global RNAi Medicine Market Concentration Ratio
3.4.1 Global RNAi Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Medicine Revenue in 2023
3.5 RNAi Medicine Key Players Head office and Area Served
3.6 Key Players RNAi Medicine Product Solution and Service
3.7 Date of Enter into RNAi Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Medicine Breakdown Data by Type
4.1 Global RNAi Medicine Historic Market Size by Type (2019-2024)
4.2 Global RNAi Medicine Forecasted Market Size by Type (2025-2030)
5 RNAi Medicine Breakdown Data by Application
5.1 Global RNAi Medicine Historic Market Size by Application (2019-2024)
5.2 Global RNAi Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNAi Medicine Market Size (2019-2030)
6.2 North America RNAi Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNAi Medicine Market Size by Country (2019-2024)
6.4 North America RNAi Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Medicine Market Size (2019-2030)
7.2 Europe RNAi Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNAi Medicine Market Size by Country (2019-2024)
7.4 Europe RNAi Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Medicine Market Size (2019-2030)
8.2 Asia-Pacific RNAi Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNAi Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific RNAi Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Medicine Market Size (2019-2030)
9.2 Latin America RNAi Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNAi Medicine Market Size by Country (2019-2024)
9.4 Latin America RNAi Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Medicine Market Size (2019-2030)
10.2 Middle East & Africa RNAi Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNAi Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa RNAi Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Medicine Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Medicine Business (2019-2024)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Detail
11.2.2 Ionis Pharmaceuticals Business Overview
11.2.3 Ionis Pharmaceuticals RNAi Medicine Introduction
11.2.4 Ionis Pharmaceuticals Revenue in RNAi Medicine Business (2019-2024)
11.2.5 Ionis Pharmaceuticals Recent Development
11.3 Suzhou Ribo Life Science Co.,Ltd.
11.3.1 Suzhou Ribo Life Science Co.,Ltd. Company Detail
11.3.2 Suzhou Ribo Life Science Co.,Ltd. Business Overview
11.3.3 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Introduction
11.3.4 Suzhou Ribo Life Science Co.,Ltd. Revenue in RNAi Medicine Business (2019-2024)
11.3.5 Suzhou Ribo Life Science Co.,Ltd. Recent Development
11.4 Sirnaomics
11.4.1 Sirnaomics Company Detail
11.4.2 Sirnaomics Business Overview
11.4.3 Sirnaomics RNAi Medicine Introduction
11.4.4 Sirnaomics Revenue in RNAi Medicine Business (2019-2024)
11.4.5 Sirnaomics Recent Development
11.5 GemmaPharma
11.5.1 GemmaPharma Company Detail
11.5.2 GemmaPharma Business Overview
11.5.3 GemmaPharma RNAi Medicine Introduction
11.5.4 GemmaPharma Revenue in RNAi Medicine Business (2019-2024)
11.5.5 GemmaPharma Recent Development
11.6 RiboBio
11.6.1 RiboBio Company Detail
11.6.2 RiboBio Business Overview
11.6.3 RiboBio RNAi Medicine Introduction
11.6.4 RiboBio Revenue in RNAi Medicine Business (2019-2024)
11.6.5 RiboBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global RNAi Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of siRNA
Table 3. Key Players of miRNA
Table 4. Key Players of piRNA
Table 5. Key Players of Others
Table 6. Global RNAi Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global RNAi Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global RNAi Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global RNAi Medicine Market Share by Region (2019-2024)
Table 10. Global RNAi Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global RNAi Medicine Market Share by Region (2025-2030)
Table 12. RNAi Medicine Market Trends
Table 13. RNAi Medicine Market Drivers
Table 14. RNAi Medicine Market Challenges
Table 15. RNAi Medicine Market Restraints
Table 16. Global RNAi Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global RNAi Medicine Market Share by Players (2019-2024)
Table 18. Global Top RNAi Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Medicine as of 2023)
Table 19. Ranking of Global Top RNAi Medicine Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by RNAi Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNAi Medicine Product Solution and Service
Table 23. Date of Enter into RNAi Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNAi Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global RNAi Medicine Revenue Market Share by Type (2019-2024)
Table 27. Global RNAi Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global RNAi Medicine Revenue Market Share by Type (2025-2030)
Table 29. Global RNAi Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global RNAi Medicine Revenue Market Share by Application (2019-2024)
Table 31. Global RNAi Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global RNAi Medicine Revenue Market Share by Application (2025-2030)
Table 33. North America RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America RNAi Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America RNAi Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe RNAi Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe RNAi Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific RNAi Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific RNAi Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific RNAi Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America RNAi Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America RNAi Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa RNAi Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa RNAi Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa RNAi Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Alnylam Pharmaceuticals Company Detail
Table 49. Alnylam Pharmaceuticals Business Overview
Table 50. Alnylam Pharmaceuticals RNAi Medicine Product
Table 51. Alnylam Pharmaceuticals Revenue in RNAi Medicine Business (2019-2024) & (US$ Million)
Table 52. Alnylam Pharmaceuticals Recent Development
Table 53. Ionis Pharmaceuticals Company Detail
Table 54. Ionis Pharmaceuticals Business Overview
Table 55. Ionis Pharmaceuticals RNAi Medicine Product
Table 56. Ionis Pharmaceuticals Revenue in RNAi Medicine Business (2019-2024) & (US$ Million)
Table 57. Ionis Pharmaceuticals Recent Development
Table 58. Suzhou Ribo Life Science Co.,Ltd. Company Detail
Table 59. Suzhou Ribo Life Science Co.,Ltd. Business Overview
Table 60. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product
Table 61. Suzhou Ribo Life Science Co.,Ltd. Revenue in RNAi Medicine Business (2019-2024) & (US$ Million)
Table 62. Suzhou Ribo Life Science Co.,Ltd. Recent Development
Table 63. Sirnaomics Company Detail
Table 64. Sirnaomics Business Overview
Table 65. Sirnaomics RNAi Medicine Product
Table 66. Sirnaomics Revenue in RNAi Medicine Business (2019-2024) & (US$ Million)
Table 67. Sirnaomics Recent Development
Table 68. GemmaPharma Company Detail
Table 69. GemmaPharma Business Overview
Table 70. GemmaPharma RNAi Medicine Product
Table 71. GemmaPharma Revenue in RNAi Medicine Business (2019-2024) & (US$ Million)
Table 72. GemmaPharma Recent Development
Table 73. RiboBio Company Detail
Table 74. RiboBio Business Overview
Table 75. RiboBio RNAi Medicine Product
Table 76. RiboBio Revenue in RNAi Medicine Business (2019-2024) & (US$ Million)
Table 77. RiboBio Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global RNAi Medicine Market Share by Type: 2023 VS 2030
Figure 3. siRNA Features
Figure 4. miRNA Features
Figure 5. piRNA Features
Figure 6. Others Features
Figure 7. Global RNAi Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global RNAi Medicine Market Share by Application: 2023 VS 2030
Figure 9. Drug Discovery & Development Case Studies
Figure 10. Therapeutics Case Studies
Figure 11. Drug Delivery Case Studies
Figure 12. Others Case Studies
Figure 13. RNAi Medicine Report Years Considered
Figure 14. Global RNAi Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global RNAi Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global RNAi Medicine Market Share by Region: 2023 VS 2030
Figure 17. Global RNAi Medicine Market Share by Players in 2023
Figure 18. Global Top RNAi Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Medicine as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by RNAi Medicine Revenue in 2023
Figure 20. North America RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America RNAi Medicine Market Share by Country (2019-2030)
Figure 22. United States RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe RNAi Medicine Market Share by Country (2019-2030)
Figure 26. Germany RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific RNAi Medicine Market Share by Region (2019-2030)
Figure 34. China RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America RNAi Medicine Market Share by Country (2019-2030)
Figure 42. Mexico RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa RNAi Medicine Market Share by Country (2019-2030)
Figure 46. Turkey RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia RNAi Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Medicine Business (2019-2024)
Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in RNAi Medicine Business (2019-2024)
Figure 50. Suzhou Ribo Life Science Co.,Ltd. Revenue Growth Rate in RNAi Medicine Business (2019-2024)
Figure 51. Sirnaomics Revenue Growth Rate in RNAi Medicine Business (2019-2024)
Figure 52. GemmaPharma Revenue Growth Rate in RNAi Medicine Business (2019-2024)
Figure 53. RiboBio Revenue Growth Rate in RNAi Medicine Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
